Considerations for Establishing Successful Coronavirus Disease Vaccination Programs in Africa

Emerg Infect Dis. 2021 Aug;27(8):2009-2016. doi: 10.3201/eid2708.203870. Epub 2021 Jun 17.

Abstract

The accelerated development of coronavirus disease (COVID-19) candidate vaccines is intended to achieve worldwide immunity. Ensuring COVID-19 vaccination is crucial to stemming the pandemic, reclaiming everyday life, and helping restore economies. However, challenges exist to deploying these vaccines, especially in resource-limited sub-Saharan Africa. In this article, we highlight lessons learned from previous efforts to scale up vaccine distribution and offer considerations for policymakers and key stakeholders to use for successful COVID-19 vaccination rollout in Africa. These considerations range from improving weak infrastructure for managing data and identifying adverse events after immunization to considering financing options for overcoming the logistical challenges of vaccination campaigns and generating demand for vaccine uptake. In addition, providing COVID-19 vaccination can be used to promote the adoption of universal healthcare, especially in sub-Saharan Africa countries.

Keywords: Africa; COVID-19; COVID-19 vaccines; SARS-CoV-2; coronavirus disease; disease control strategies; disease transmission; pandemics; public health logistics; respiratory infections; severe acute respiratory syndrome coronavirus 2; sub-Saharan Africa; vaccination coverage; vaccination programs; vaccinations; viruses; zoonoses.

Publication types

  • Review

MeSH terms

  • Africa South of the Sahara / epidemiology
  • COVID-19 Vaccines*
  • COVID-19*
  • Humans
  • Immunization Programs
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines